LINEAGE CELL THERAPEUTICS IN (LCTX) Institutional Ownership

LCTX is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.76M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $1.76M in its June 30, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's LCTX position is now estimated to be worth approximately $1.39M, representing an estimated loss of -21.37% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward LINEAGE CELL THERAPEUTICS IN (LCTX).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q2 20261$1,761,7261,344,829
Q1 20261$3,357,6582,125,100
Q4 20251$4,016,0162,404,800
Q3 20251$3,220,5201,905,633
Q2 20251$1,789,6971,972,335
Q1 20251$1,034,7882,291,381
Q4 20241$1,147,2442,283,072
Q3 20241$178,435197,100
Q2 20241$582,046583,622
Q1 20241$785,000530,600
Q4 20231$164,000150,000
Q3 20231$70,00059,700

Related LCTX Institutional Insights: